The United States leads the global export of insulin not in dosage forms, with a significant value in 2023. The data indicates varied trends among countries, with the Czech Republic and Austria showing modest growth, while nations like Denmark, France, and Italy have faced declines. Australia experienced a notable increase of over 17%, contrasting Switzerland's substantial decrease. The collective CAGR over the last five years highlights an average growth pattern, although individual country performances vary.
Future trends to watch include advancements in biotechnology that may impact insulin production efficiency, potential shifts in regulatory frameworks affecting trade, and emerging markets in Asia and Africa potentially altering current export dynamics.
Top countries in Export of Insulin Not in Dosage Forms by Country
| # | 10 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 80,355,000 | 2023 | -0.17% | -3.02% | View data |
| 2 | 2 Czech Republic | 1,767,500 | 2023 | +5.41% | +2.32% | View data |
| 3 | 3 Denmark | 1,197,900 | 2023 | -5.34% | -7.08% | View data |
| 4 | 4 United Kingdom | 505,790 | 2023 | +1.22% | +3.08% | View data |
| 5 | 5 France | 400,500 | 2023 | -4.47% | -4.13% | View data |
| 6 | 6 Austria | 310,980 | 2023 | +3.71% | +3.62% | View data |
| 7 | 7 Italy | 61,810 | 2023 | -10.63% | -13.1% | View data |
| 8 | 8 South Africa | 39,590 | 2023 | -10.85% | -8.05% | View data |
| 9 | 9 Australia | 21,680 | 2023 | -1.22% | +17.08% | View data |
| 10 | 10 Switzerland | 21,340 | 2023 | -9.82% | -18.91% | View data |
